TB is the leading cause of illness and death among people living with HIV (PLHIV). It increases the occurrence of other infections, increases the rate at which HIV progresses, and influences antiretroviral therapy (ART) in various ways. Late diagnosis and delayed treatment of TB contributes to increased death rates in PLHIV.
A new strategy for tuberculosis control in high-HIV prevalence populations has been developed and the various approaches are summarised in Box 16.2.
If an HIV-positive patient develops symptoms of TB, it is essential you encourage them to seek treatment and refer them to a treatment facility.
Activities directed against TB control are:
BCG vaccination is described in the Immunization Module.
Activities directed against HIV (and therefore indirectly against tuberculosis) are:
All of these topics are covered in detail in the Study Sessions on HIV/AIDS in Part 3 of this Module